or Try an Advanced Search...

    IBD 50 Stocks List

    Symbol Grade Name % Change
    MNDY D monday.com Ltd. 0.09
    ALNY D Alnylam Pharmaceuticals, Inc. 2.02
    BGNE D BeiGene, Ltd. 3.77
    YOU D Clear Secure, Inc. -0.64
    HROW D Harrow Health, Inc. 3.04
    ZETA D Zeta Global Holdings Corp. 12.81
    VITL D Vital Farms, Inc. -0.43
    ARM F Arm Holdings plc -0.64
    LNTH F Lantheus Holdings, Inc. 7.16
    PACS F PACS Group, Inc. 0.00
    View As Page of Charts
    Related Industries: Aerospace & Defense Apparel Retail Biotechnology Capital Markets Computer Systems Conglomerates Contract Manufacturers Diagnostics & Research Diversified Industrials Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Electronic Components Engineering & Construction Farm Products Footwear & Accessories Health Information Services Information Technology Services Insurance - Specialty Insurance Brokers Leisure Lodging Media - Diversified Medical Care Facilities Rental & Leasing Services Semiconductors Software - Application Software - Infrastructure Specialty Industrial Machinery Specialty Retail
    Related Stock Lists: S&P 500 Aerospace Consumer Electronics E Commerce Electronics Fintech Transport Applied Sciences Audiovisual Brokerage Building Automation Building Biology Building Engineering Buy Now Pay Later Cement Services Chemical Comfort Systems Usa Commodity Markets Communication Networks Communications Equipment

    Related ETFs - A few ETFs which own one or more of the above listed IBD 50 stocks.

    Symbol Grade Name Weight
    FFTY A Innovator IBD 50 Fund ETF 18.13
    IGV A iShares Expanded Tech-Software Sector ETF 13.6
    SHLD B Global X Defense Tech ETF 10.38
    FNGS A MicroSectors FANG ETNs due January 8, 2038 10.11
    FNGO A MicroSectors FANG Index 2X Leveraged ETNs due January 8, 2038 10.11
    View all IBD 50 ETFs...
    Compare ETFs
    Compare FFTY to FNGO Compare FFTY to IGV Compare FNGS to FNGO

        IBD 50 Stocks Recent News

        Date Stock Title
        Nov 20 HROW Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
        Nov 20 ARM Why Nvidia earnings could be a sink-or-swim moment for this bull market
        Nov 20 LNTH Lantheus Holdings launches $250M share buyback program
        Nov 20 LNTH Lantheus Announces Share Repurchase Program
        Nov 19 MNDY PLTR, MNDY, or SOFI: Which Growth Stock Is the Most Attractive Pick?
        Nov 19 VITL Is Vital Farms (VITL) The Best Agriculture Stock To Buy Right Now?
        Nov 19 BGNE Labcorp CFO Glenn Eisenberg Announces Plans to Retire
        Nov 19 BGNE BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA
        Nov 19 MNDY TravelPerk appoints monday.com’s CFO Eliran Glazer to be Chair of the Audit Committee and join the Board
        Nov 18 PACS Seventeen PACS Post Acute Locations Honored by Newsweek Magazine
        Nov 18 VITL Vital Farms to Participate in Furey Research Partners 11th Annual Hidden Gems Conference
        Nov 18 ZETA Why Zeta (ZETA) Stock Is Trading Up Today
        Nov 18 ALNY Alnylam releases encouraging interim data on nucresiran for ATTR amyloidosis
        Nov 18 ZETA Zeta Global Stock Soars 9% After CEO's Bold $3M Insider Bet
        Nov 18 ZETA Zeta Global stock jumps on ~$3M intended share purchases by management
        Nov 18 ALNY ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
        Nov 18 VITL Vital Farms Reimagines the Iconic Gingerbread House; Releases Limited-Edition Holiday ‘Gingerbread Farmhouse Kit’ in Partnership with Supernatural and King Arther Baking Company
        Nov 18 ZETA Zeta Global to Hold a Webinar to Discuss its Accounting Processes and Controls, Data Collection Policies, and Privacy Oversight
        Nov 18 ZETA Zeta Global Announces Intended Share Purchases by CEO and Members of Senior Leadership and Board of Directors
        Nov 18 ALNY Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
        Related Industries: Aerospace & Defense Apparel Retail Biotechnology Capital Markets Computer Systems Conglomerates Contract Manufacturers Diagnostics & Research Diversified Industrials Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Electronic Components Engineering & Construction Farm Products Footwear & Accessories Health Information Services Information Technology Services Insurance - Specialty Insurance Brokers Leisure Lodging Media - Diversified Medical Care Facilities Rental & Leasing Services Semiconductors Software - Application Software - Infrastructure Specialty Industrial Machinery Specialty Retail
        Related Stock Lists: S&P 500 Computing Business Intelligence Clothing Footwear Telecommunications Analytics Antibodies Antibody Apparel Asset Management Athletic Footwear Authentication Autocad Big Data Biology Biopharmaceutical Biotechnology Broadband Cable Systems
        IBD 50

        The IBD 50 is a list of 50 top-performing growth stocks compiled by Investor's Business Daily (IBD). The list is updated weekly and includes stocks from a variety of industries. The stocks are selected based on their performance in terms of earnings, sales, and other fundamental and technical criteria. The IBD 50 is a great resource for investors looking for potential investments with strong growth potential.

        Browse All Tags